GSK plc
GSK
$38.56
$0.1550.40%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.98B | 3.26B | 3.17B | 5.09B | 5.65B |
| Total Depreciation and Amortization | 3.34B | 3.00B | 3.26B | 2.76B | 2.52B |
| Total Amortization of Deferred Charges | 270.22M | 270.22M | 252.16M | 252.16M | 252.16M |
| Total Other Non-Cash Items | 1.66B | 1.50B | -412.00M | -257.30K | 373.94M |
| Change in Net Operating Assets | -617.52M | 376.04M | 3.12B | 1.29B | 831.06M |
| Cash from Operations | 8.63B | 8.40B | 9.39B | 9.39B | 9.62B |
| Capital Expenditure | -1.74B | -1.79B | -1.70B | -1.68B | -1.67B |
| Sale of Property, Plant, and Equipment | 83.20M | 83.21M | 13.79M | 26.41M | 27.65M |
| Cash Acquisitions | -1.14B | -1.05B | -964.85M | -1.04B | -2.75B |
| Divestitures | -20.40M | -22.94M | -25.23M | -23.86M | 65.08M |
| Other Investing Activities | -38.65M | 1.17B | 2.84B | 3.21B | 2.64B |
| Cash from Investing | -2.85B | -1.60B | 164.06M | 493.65M | -1.68B |
| Total Debt Issued | 3.42B | 1.34B | -1.41B | -2.02B | -329.00M |
| Total Debt Repaid | -2.57B | -2.73B | -2.99B | -2.87B | -2.98B |
| Issuance of Common Stock | 14.00M | 20.00M | 21.00M | 20.00M | 22.00M |
| Repurchase of Common Stock | -247.00M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.17B | -3.12B | -3.04B | -2.97B | -2.84B |
| Other Financing Activities | -936.00M | -910.00M | -698.00M | -770.00M | -837.00M |
| Cash from Financing | -3.61B | -6.03B | -9.42B | -10.04B | -8.00B |
| Foreign Exchange rate Adjustments | -59.23M | -69.46M | -120.66M | -47.30M | -108.55M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.11B | 698.87M | 17.39M | -199.30M | -169.60M |